Looks like you clickedhttps://www.urotoday.com/conference-highlights/asco-gu-2019/asco-gu-2019-prostate-cancer/110300-asco-gu-2019-the-cheiron-study-a-multicentric-phase-ii-randomized-trial-of-docetaxel-plus-enzalutamide-versus-docetaxel-as-first-line-chemotherapy-for-patients-with-mcrpc.html
If you do not want to visit that page, you can close this browser tab.
